MyAverix Finance MyAverix Finance

STU

Crinetics Pharmaceuticals Inc (6Z4)

Crinetics Pharmaceuticals Inc (6Z4) is listed on STU. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 6Z4

P/E ratio
18.00

Crinetics Pharmaceuticals Inc (6Z4) — FAQ

What is 6Z4's P/E ratio?

The price-to-earnings (P/E) ratio for Crinetics Pharmaceuticals Inc (6Z4) is 18.00 (data as of 2026-05-24).

Does Crinetics Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Crinetics Pharmaceuticals Inc (6Z4). Check the MyAverix Finance app for the latest dividend data.

What exchange is 6Z4 listed on?

6Z4 is listed on STU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play